Agarwala, Anandita
Asim, Ramsha
Ballantyne, Christie M.
Article History
Accepted: 13 March 2024
First Online: 27 March 2024
Declarations
:
: Dr. Ballantyne reports receiving consulting fees and research grants to his institution from Abbott Diagnostics, Akcea, Amgen, Arrowhead, Esperion, Ionis, Novartis, Novo Nordisk, Merck, Regeneron, and Roche Diagnostics. The other authors report that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.